NRX Pharmaceuticals, Inc. (NRXP) SEC filings
NRXP SEC filings moved a median of 0.00% by the close. NRXP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NRXP overview →
96 measured NRXP SEC filing events.
Where these NRXP SEC filings landedvs 95 measured NRXP SEC filing reactions
| Middle 50% of NRXP SEC filing reactions | -4.00% to +5.00% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 95 |
Point-in-time · zero look-ahead
Half of the 95 NRXP SEC filing events with a measured close landed between -4.00% and +5.00%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K NRX Pharmaceuticals, For: Sep 29 | SEC filing · Form 8-K | -0.17% | +1.73% | |
| Form 8-K NRX Pharmaceuticals, For: Sep 15 | SEC filing · Form 8-K | +0.74% | -1.18% | |
| Form 8-K NRX Pharmaceuticals, For: Sep 08 | SEC filing · Form 8-K | +0.89% | +3.56% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 17 | SEC filing · Form 8-K | +5.16% | +10.64% | |
| Form 10-Q NRX Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +5.16% | +10.64% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -1.45% | +3.77% | |
| Form 8-K NRX Pharmaceuticals, For: Jul 21 | SEC filing · Form 8-K | +0.34% | +1.59% | |
| Form 8-K NRX Pharmaceuticals, For: Jun 03 | SEC filing · Form 8-K | -1.59% | +1.22% | |
| Form 8-K NRX Pharmaceuticals, For: Jun 02 | SEC filing · Form 8-K | -3.60% | +12.19% | |
| Form 10-Q NRX Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.06% | -8.11% | |
| Form 8-K NRX Pharmaceuticals, For: Mar 23 | SEC filing · Form 8-K | +2.56% | +12.09% | |
| Form 10-K NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.27% | +13.30% | |
| Form DEFA14A NRX Pharmaceuticals, | SEC filing · Form DEFA14A | -0.53% | +0.53% | |
| Form ARS NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +2.21% | +4.14% | |
| Form DEF 14A NRX Pharmaceuticals, For: Mar 23 | SEC filing · Form DEF | +2.21% | +4.14% | |
| Form 8-K NRX Pharmaceuticals, For: Feb 17 | SEC filing · Form 8-K | -2.78% | +0.00% | |
| Form PRE 14A NRX Pharmaceuticals, For: Mar 23 | SEC filing · Form PRE | -2.78% | +0.00% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 27 | SEC filing · Form 8-K | -0.93% | -5.56% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 12 | SEC filing · Form 8-K | -2.69% | -2.24% | |
| Form 8-K NRX Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | -0.19% | +1.94% | |
| Form EFFECT NRX Pharmaceuticals, | SEC filing · Form EFFECT | -0.84% | +0.42% | |
| Form S-3/A NRX Pharmaceuticals, | SEC filing · Form S-3 | -0.81% | -5.71% | |
| Form 8-K NRX Pharmaceuticals, For: Nov 20 | SEC filing · Form 8-K | -5.60% | -2.00% | |
| Form 8-K/A NRX Pharmaceuticals, For: Sep 08 | SEC filing · Form 8-K | +0.46% | +5.16% | |
| Form 10-Q NRX Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.87% | -7.86% | |
| Form 8-K NRX Pharmaceuticals, For: Oct 17 | SEC filing · Form 8-K | -0.47% | -1.56% | |
| Form 8-K NRX Pharmaceuticals, For: Sep 24 | SEC filing · Form 8-K | +0.17% | +1.72% | |
| Form 8-K NRX Pharmaceuticals, For: Sep 08 | SEC filing · Form 8-K | +1.07% | +7.14% | |
| Form 8-K NRX Pharmaceuticals, For: Sep 02 | SEC filing · Form 8-K | +0.00% | +10.53% | |
| Form 10-Q NRX Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -8.30% | -3.50% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 18 | SEC filing · Form 8-K | -2.83% | — | |
| Form 8-K NRX Pharmaceuticals, For: Aug 11 | SEC filing · Form 8-K | -4.34% | +4.71% | |
| Form NT 10-Q NRX Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | -4.34% | +4.71% | |
| Form RW NRX Pharmaceuticals, | SEC filing · Form RW | -1.22% | -0.30% | |
| Form S-3 NRX Pharmaceuticals, | SEC filing · Form S-3 | -5.33% | -2.82% | |
| Form 8-K NRX Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | -2.81% | -1.87% | |
| Form 8-K NRX Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | -3.02% | +1.51% | |
| Form 10-Q NRX Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.43% | +4.25% | |
| Form 8-K NRX Pharmaceuticals, For: May 13 | SEC filing · Form 8-K | +6.44% | +13.37% | |
| Form 10-K/A NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.24% | -1.42% | |
| Form 8-K NRX Pharmaceuticals, For: Apr 17 | SEC filing · Form 8-K | +4.35% | -0.53% | |
| Form 8-K NRX Pharmaceuticals, For: Mar 17 | SEC filing · Form 8-K | -5.46% | -5.91% | |
| Form 10-K NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.25% | -12.77% | |
| Form D NRX Pharmaceuticals, | SEC filing · Form D | +0.00% | -1.59% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 28 | SEC filing · Form 8-K | +0.44% | -5.61% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 27 | SEC filing · Form 8-K | -4.46% | -4.78% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 15 | SEC filing · Form 8-K | +0.29% | -15.80% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 07 | SEC filing · Form 8-K | +1.56% | -8.55% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 06 | SEC filing · Form 8-K | +3.72% | +28.99% | |
| Form 8-K NRX Pharmaceuticals, For: Nov 18 | SEC filing · Form 8-K | -0.81% | -1.63% | |
| Form 8-K NRX Pharmaceuticals, For: Nov 14 | SEC filing · Form 8-K | -4.41% | +4.84% | |
| Form 10-Q NRX Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.59% | |
| Form S-1 NRX Pharmaceuticals, | SEC filing · Form S-1 | — | -0.85% | |
| Form 8-K NRX Pharmaceuticals, For: Oct 30 | SEC filing · Form 8-K | -0.69% | -5.52% | |
| Form 8-K NRX Pharmaceuticals, For: Oct 10 | SEC filing · Form 8-K | -4.80% | -1.60% | |
| Form 8-K NRX Pharmaceuticals, For: Oct 07 | SEC filing · Form 8-K | +1.42% | -6.38% | |
| Form DEF 14A NRX Pharmaceuticals, For: Oct 08 | SEC filing · Form DEF | +3.65% | +2.52% | |
| Form PRE 14A NRX Pharmaceuticals, For: Oct 08 | SEC filing · Form PRE | +4.02% | -3.02% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 14 | SEC filing · Form 8-K | +0.05% | +2.15% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 14 | SEC filing · Form 8-K | -2.14% | -6.95% | |
| Form 10-Q NRX Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -2.14% | -6.95% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | -2.14% | -6.95% | |
| Form 8-K NRX Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +0.95% | -1.55% | |
| Form 8-K NRX Pharmaceuticals, For: Jun 21 | SEC filing · Form 8-K | +0.78% | -5.43% | |
| Form 8-K NRX Pharmaceuticals, For: Jun 13 | SEC filing · Form 8-K | +0.00% | -8.62% | |
| Form 8-K NRX Pharmaceuticals, For: May 21 | SEC filing · Form 8-K | -2.47% | +8.52% | |
| Form 8-K NRX Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | +1.52% | +8.31% | |
| Form 10-Q NRX Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -3.10% | +0.00% | |
| Form 8-K NRX Pharmaceuticals, For: Apr 24 | SEC filing · Form 8-K | +2.91% | +5.83% | |
| Form 10-K/A NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.14% | +13.16% | |
| Form 8-K NRX Pharmaceuticals, For: Apr 17 | SEC filing · Form 8-K | -1.61% | -3.23% | |
| Form 8-K NRX Pharmaceuticals, For: Apr 15 | SEC filing · Form 8-K | -3.16% | -9.47% | |
| Form 8-K NRX Pharmaceuticals, For: Apr 01 | SEC filing · Form 8-K | -2.52% | +1.42% | |
| Form 10-K NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.34% | +11.70% | |
| Form 8-K NRX Pharmaceuticals, For: Mar 28 | SEC filing · Form 8-K | +6.34% | +11.70% | |
| Form 8-K NRX Pharmaceuticals, For: Mar 21 | SEC filing · Form 8-K | +3.85% | +7.69% | |
| Form DEFA14A NRX Pharmaceuticals, | SEC filing · Form DEFA14A | -4.08% | +3.08% | |
| Form DEFA14A NRX Pharmaceuticals, | SEC filing · Form DEFA14A | +0.57% | -8.73% | |
| Form DEFA14A NRX Pharmaceuticals, | SEC filing · Form DEFA14A | +3.38% | -9.36% | |
| Form DEF 14A NRX Pharmaceuticals, For: Mar 21 | SEC filing · Form DEF | -3.45% | -23.81% | |
| Form 8-K NRX Pharmaceuticals, For: Mar 05 | SEC filing · Form 8-K | +1.45% | -4.49% | |
| Form 8-K NRX Pharmaceuticals, For: Feb 27 | SEC filing · Form 8-K | -0.52% | +16.94% | |
| Form 8-K NRX Pharmaceuticals, For: Feb 07 | SEC filing · Form 8-K | -1.79% | -1.58% | |
| Form 8-K NRX Pharmaceuticals, For: Feb 09 | SEC filing · Form 8-K | -1.57% | -1.22% | |
| Form 8-K NRX Pharmaceuticals, For: Feb 01 | SEC filing · Form 8-K | +0.00% | -0.25% | |
| Form 8-K NRX Pharmaceuticals, For: Jan 16 | SEC filing · Form 8-K | +2.14% | +4.33% | |
| Form 8-K NRX Pharmaceuticals, For: Dec 28 | SEC filing · Form 8-K | -0.98% | +8.48% | |
| Form PRE 14A NRX Pharmaceuticals, For: Dec 29 | SEC filing · Form PRE | -0.98% | +8.48% | |
| Form 8-K NRX Pharmaceuticals, For: Dec 19 | SEC filing · Form 8-K | +2.16% | +8.65% | |
| Form 8-K/A NRX Pharmaceuticals, For: Nov 15 | SEC filing · Form 8-K | +5.87% | +5.20% | |
| Form ARS NRX Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +5.87% | +5.20% | |
| Form DEF 14A NRX Pharmaceuticals, For: Dec 19 | SEC filing · Form DEF | +5.87% | +5.20% | |
| Form 8-K NRX Pharmaceuticals, For: Nov 15 | SEC filing · Form 8-K | -1.75% | -6.78% | |
| Form 10-Q NRX Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.98% | -6.58% | |
| Form 8-K NRX Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | -2.86% | +0.00% | |
| Form 8-K NRX Pharmaceuticals, For: Oct 17 | SEC filing · Form 8-K | -2.83% | -0.39% |
Keep exploring
More NRXP: earnings → · analyst actions → · NRXP overview →